Сообщения за Январь, 2016Показать все
Eli Lilly profitiert von Novartis-Zukauf und neuen Produkten
Johnson & Johnson (JNJ) Shares Bought by Armstrong Henry H Associates Inc.
Atlas Brown Inc. Has $457,000 Position in Merck & Co., Inc.
Six people being tested for Zika virus in Bexar County
26,193 Shares in Biogen Inc (BIIB) Acquired by Accident Compensation Corp
Among high risk kids, both boys and girls are victims of dating violence
Ga. Police Chase Ends In Deaths, Drug Trafficking Charges
What To Buy In This Biotech Sell-Off
State confirms 3 SC residents tested for Zika virus
Gilead: Detailed Insight And Interpretation Behind The Headlines: Should You Be Scared?
Hillary, Don't Attack Valeant, Attack Lawmakers
Danbury-based firm lays off half its staffers
More airlines offer Zika refunds to pregnant women
FDA OKs Merck hepatitis C drug, adding to patient choices
Amgen trounces Street views with 39 pct. jump in 4Q profit
Late run sees ASX finish on a high
Records: Site had proper procedures before listeria outbreak
Roche blickt optimistisch in die Zukunft
Obama creates new federal task force on cancer
Stamford audio giant drops after bell
Bristol-Myers posts 4Q loss, but beats views as sales rise
IBM: Will Big Data Analytics + Big Pharma = Big Profits?
Regeneron wants to build a second East Greenbush campus
3 Must Own Biotech Stocks For February
Massachusetts is investigating high cost of hepatitis C drug
Novartis geht für 2016 von starker Generika-Konkurrenz aus
Biogen 4Q profit falls on costs, but tops forecasts
Things to know about the mosquito villain in Zika outbreaks
Supergroup PLC's (SGP) "Hold" Rating Reaffirmed at Numis Securities Ltd
United, American offering refunds for travel to Zika areas
The Latest: Virginia resident tests positive for Zika virus
ASHP Publishes Guide for Treating Obese Patients
The Latest: US starts research into possible Zika vaccine
Oil fuels 'schizophrenic' Wall Street rebound
Morphosys erhält Meilensteinzahlung von Bayer
Big U.S. biotech profit reports could boost industry's swooning shares
Open-source Laser Fabrication Lowers Costs for Cancer Research
Johnson & Johnson beats 4Q profit forecasts
Biotech Weekly: The NASDAQ Sub $10 Million Market Cap Club
Biotech Deserves A Piece Of Every Dividend Growth Portfolio
Reasons to Expect Strong Bristol-Myers Earnings
Women advised to avoid pregnancy as Zika virus spreads
Johnson & Johnson Earnings May Be Scrutinized For Deal Buzz, Product Snags
European organic and biotech industries clash over plant breeding techniques
Democratic senator blocks Obama's pick to head FDA
Gilead Closes Galapagos Deal- Opens Up Massive Market Opportunity
Novavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023
GSK, Astra, J&J link with universities in new drug research fund
QLT Inc. (QLTI) Earns Hold Rating from Zacks Investment Research
Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research
LDC und Roche wollen gemeinsam innovative Wirkstoffprojekte vorantreiben
USC Eye Study Finds Near-Sightedness Growing
ETF Update: 4 New Launches And 2 Closures
Flint hospital suspected river, Legionnaires' outbreak link
Lenox Wealth Advisors Divests From Position in SPDR S&P Biotech
Medical Marijuana Biotech Brands - Potbotics is a Biotech Startup...
Mitchell Sinkler & Starr Continues to Hold Position in Novartis AG
CBC retracts anti-supplements story based on faulty tests
McKesson Co. (MCK) Position Held by Private Asset Management
Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan
Galena Biopharma Inc (GALE) Receives "Outperform" Rating from Oppenheimer
Is your skin scrub enviro-friendly? More companies agree not to use microbeads
Health officials probe tie between Zika, paralyzing syndrome
1 dead in listeria outbreak linked to packaged lettuce
Astellas Pharma $8.50 Tender Offer For Ocata Therapeutics Offer Fails Again
Meningitis B vaccine shortage halts new private jabs
MannKind Launches New Direction For Afrezza
Zika virus likely to spread to southern United States
UPDATE 1-J&J stops trials of drug similar to one linked to brain death in France
An Increased Emphasis on "Proportional Discovery"
Goldman Plans To Dominate M&A In 2016
Roche erhält für Leukämie-Medikament Breakthrough Therapy-Status
UPDATE 1-Five charged in U.S. with stealing secrets from GlaxoSmithKline
Five charged in US with trying to steal from pharma giant
The Latest: Austria calls for EU asylum reform
5 charged in alleged scheme to steal drug secrets
More
Spreading Zika virus a new economic strain for Latin America
Namenswechsel: Cytos Biotechnology wird zu Kuros Biosciences
Johnson & Johnson baut Stellen ab
Why You Still Have to Dress for Success
What You Can Achieve With Dividend Investing, A Johnson & Johnson Case Study
Global Vaccine promises $5 million to develop Ebola vaccine
Insider Buying: Neptune Technologies & Bioressources Inc (NTB)...
CDC: Ask pregnant women about trips to Zika outbreak areas
Johnson & Johnson to cut about 3,000 jobs in medical devices
FBI: Violent crime rose in first 6 months of 2015 over 2014
Merck beruft neue Mitglieder der Geschäftsleitung
High court rejects appeal over $63M judgment in Motrin case
MannKind: Out With The New And In With The Old Game-Plan For Success
Kenyan man charged for sharing photos of Somalia victims
Carnage In Biotech: What's Hot And What's Not
Family Time: Road to recovery: What you need to know about addiction
Celsion Co. (CLSN) Raised to "Buy" at Zacks Investment Research
Effort to curb overuse of antibiotics amid cold, flu seasons
MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook
Studienabbrecher sind begehrt
Merck & Co vs. Merck KGaA: US-Konzern mit neuer Klage im Namensstreit
Zacks Investment Research Downgrades Bayer AG (BAYRY) to Hold
Jamaica advises women to delay pregnancy due to Zika virus
Biotech investor: 'None of us were as smart as we thought we were'
Shire PLC (SHP) Lifted to Outperform at BNP Paribas
Landscape Shifting for M&A in 2016
Johnson & Johnson (JNJ) Receives "AAA" Credit Rating
Zacks Investment Research Upgrades QLT Inc. (QLTI) to "Buy"
Celgene Co. (CELG) Receives New Coverage from Analysts at Standpoint Research
Hirntod nach Medikamententest in Frankreich
Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA
Novo Nordisk A/S (NVO) Receives Sell Rating from Zacks Investment Research
Pfizer Inc. (PFE) Sees Large Increase in Short Interest
Baby born in Hawaii with brain damage confirmed to have Zika infection
Haiti: Six years after quake, UN cites progress but warns of 'deteriorating' situation
MannKind Co. (MNKD) Upgraded to "Buy" at Zacks Investment Research
What Pharma/Biotech Investors Need To Know About Adaptive Trials
Sinovac Biotech Ltd. (SVA) Sees Significant Increase in Short Interest
Major drugmakers push back in US price debate
Pregnant women told to avoid countries with Zika outbreaks
Shark Tank funds fewer women than men, with less money
Pregnant women told to avoid countries with Zika outbreaks
These 6 Things Need To Happen Before Gilead Shares Go Higher
Merck pays $830 M to settle class-action case over Vioxx
10 biotech stocks to buy at 'silly' cheap prices
Raymond James Trust Buys $13,314,000 in Merck & Co., Inc. (MRK) Shares
ASHP Disappointed in MedPAC Recommendation to Congress on 340B
Johnson & Johnson (JNJ) Position Decreased by RNC Capital Management
Report: Cruise ship stomach sickness becoming less common
Why Confirmation Bias Is A Portfolio Killer
Zacks: Analysts Set $6.00 Price Target for Sinovac Biotech Ltd.
Alstom S.A. (ALO) Given a a 31.00 Price Target at S&P Equity Research
a Stay of Litigation Pending Ipr Does Not Provide a Basis For Extending 30-Stay of Fda Anda Approval
At Biotech Party, Gender Diversity Means Cocktail Waitresses
CDC: Strong signs Brazil birth defects are tied to mosquito
Unlocking Deep Value With Arrowhead Research
Teens regularly exposed to secondhand smoke
Childrena s cough syrup recall: What parents should know
Drug Firms Team Up on Cancer Trials
Drugmakers ring in 2016 with hefty price hikes
Most actively traded companies on the TSX
Children's Cough Medicine Recalled Due to Potential Overdose
Company recalls children's cough medicine
Alzheimer: Evotec erreicht wichtigen Meilenstein
Milliardendeal in der Pharmabranche
A (Potentially) Final Look At MannKind
Pfizer, Allergan CEOs: Tie-up aims to produce more meds, sales, isn't focused on cutting costs
No, Virginia; Biotech Is Not In A Bubble
Market Extra: As biotech stocks knife under their 'Hillary' low, analysts still say buy 'em
U.S. copy of GSK's Advair a step closer as Mylan files generic version
Johnson & Johnson: Is This What You Were Waiting For?
Twombly's Teeth
Wall Street Closes Mostly Higher as Oil Drops A...
Children's cold syrup recall expands
Emergent Biosolutions Announces Preliminary 2015 Financial Results,...
High court won't hear appeal over $124M drug penalty
Trial of Freddie Gray van driver delayed by appeals court
Shire to Combine with Baxalta in Deal Valued at About $32 Billion
West Virginia Sues Prescription Drug Wholesaler For 'Flooding' State
Alexion Pharmaceuticals, Inc. (ALXN) Position Decreased by EQIS Capital Management
Illumina, partners make $100 million bet to detect cancer via blood test
Transaktionen "historischen Ausmaßes" im Chemie- & Pharma-Bereich in 2016 erwartet
Fired Novo Nordisk rep claims retaliation in miscarriage discrimination suit
E-cigarette ads reach 7 in 10 young adults, CDC says
Merck & Co., Inc. (MRK) Shares Sold by Kempner Capital Management
Barclays Increases Hologic, Inc. (HOLX) Price Target to $42.00
Fragasso Group Has $2,482,000 Stake in Johnson & Johnson
Mead Johnson Nutrition CO (MJN) Cut to Sell at Zacks Investment Research
GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas
Astorino announces $1.2 bilion private sector investment in biotech complex
Belviq Sales Close Out 2015 With A Slump
Pfizer Hikes Prices for Over 100 Drugs on January 1
Biodel: A Beaten Down Biotech Trading At A Large Discount
West Virginia attorney general sues drug wholesaler
Biotech Bargains Abound
Healios and Athersys Enter Into Regenerative Medicine Partnership for ...
Joseph Podolski Purchases 11,677 Shares of Repros Therapeutics Inc (RPRX) Stock
Zoo staff infected by TB after exposure to elephants
Huimin Wang Sells 13,650 Shares of Edwards Lifesciences Corp (EW) Stock
Claims Are Construed In Nameda Dispute
2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
Evotec und UCB gehen mehrjährige Vereinbarung im Bereich Substanzverwaltung ein
CDC: This Is America's Most Sleep-Deprived Group
Agenus Inc (AGEN) Given Buy Rating at HC Wainwright
EQIS Capital Management Boosts Stake in Sinovac Biotech Ltd.
Jefferies' Best Biotech Ideas For 2016
DoctoRx Positions For 2016: My No. 1 Risk Factor Is The Flood Of Money Into Biotech
The MannKind Story Has Ended
Pharmakonzern Eli Lilly legt Latte nur vorsichtig höher
Biotech stocks to get the heart racing...or slowing
Valeant names Howard Schiller as interim CEO
Has Valeant Put Pearson In Its Rear View?
Health agency takes on advertising for electronic cigarettes
CEO Frazier: Merck is eager for deals, sees strong prospects for drugs for cancer, hepatitis C
A rare stumble for biotech pioneer Alfred Mann
Actelion Sees Uptravi Price Of $160,000-170,000/Patient
Esperion Therapeutics: Too Much Uncertainty To Go Long
US indexes slip; GM, Ford fall after missing sales forecasts
US stocks slip; GM and Ford fall after sales reports
Premarket Biotech Digest: Exelixis Rallies, Shire-Baxalta Deal, Lipocine Commences Mid-Stage Study
Drugmaker Lilly's 2016 forecast misses Street expectations
Chinese Authorities Flood Markets With Cash to Try to Stem Selling
Cytokinetics, Inc. (CYTK) Downgraded to Hold at Zacks Investment Research
AJHP Reveals Extensive Redesign with January 15 Issue
Heart Failure Related Deaths on the Rise
Frutarom invests in algae startup for food, cosmetic products
Press release distribution, EDGAR filing, XBRL, regulatory filings
Zacks Investment Research Upgrades Shire PLC (SHPG) to "Hold"
Gilead, Other Biotechs Selling Off On Market Weakness
Eli Lilly and Co (LLY) Earns "Buy" Rating from Jefferies Group
3 Must Own Biotech Stocks In 2016
Teva, Active Biotech halt higher doses of oral MS drug in trials
Pfizer: A Dividend Growth Case Study
Navidea Biopharmaceuticals to Present at Biotech Showcase 2016
Enterovirus D68 linked to illegal immigration is behind fatal...
AstraZeneca plc (AZN) Receives "Buy" Rating from Jefferies Group
Valeant Pharmaceuticals Intl's (VRX) "Hold" Rating Reaffirmed at Mizuho
Biogen Inc (BIIB) Rating Increased to Overweight at Piper Jaffray
2016 brings promise for biotech industry in Cleveland
Underwriters buy additional $658 mln in Teva Pharm shares